In addition, the effect of cancer-derived mutations in SMG1 (located within 248 aa–910 aa and 2,200 aa–2,400 aa) was characterized, and their effects on the binding affinity and stability in the presence of SMG8, SMG9, and UPF1 were predicted. The gene discussed is SMG9; the disease is cancer.